Current Report Filing (8-k)
30 Octubre 2014 - 1:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report (Date of earliest event reported): October 27,
2014
______________
Medical International Technology, Inc.
(Exact name of Company as specified in its charter)
______________
| Colorado |
000-31469 |
84-1509950 |
| (State or other jurisdiction |
(Commission |
(IRS Employer |
| of incorporation) |
File Number) |
Identification No.) |
1872 Beaulac, Ville Saint-Laurent
Montreal,
Quebec, Canada HR4 2E9
(Address of principal executive offices) (Zip
Code)
(514) 339-9355
Company’s telephone number, including
area code
Not Applicable
(Former name or former address, if
changed since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the Company under
any of the following provisions:
| [ ] |
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425) |
| [ ] |
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12) |
| [ ] |
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] |
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Section 4. Matters Related to Accountants and Financial
Statements
Item 4.01 Changes in Company's Certifying Accountant.
| (1) |
Previous Independent Registered Public Accounting
Firm |
| |
|
|
|
(i) |
On August 29, 2014, PS STEPHENSON & CO.,
P.C.(“STEPHENSON”), the independent registered public accounting firm of
Medical International Technology, Inc.(the “Company”) notified the Company
that STEPHENSON declined to stand for re-election. STEPHENSON noted
changes within their firm and their firm is no longer performing assurance
services for issuer clients in their resignation letter to the
Company. |
| |
|
|
|
(ii) |
The report of STEPHENSON on the financial statements of
the Company as of September 30, 2013 and 2012 and for the fiscal years
then ended did not contain an adverse opinion or disclaimer of opinion and
were not qualified or modified as to uncertainty, audit scope or
accounting principles other than an explanatory paragraph as to a going
concern. |
| |
|
|
|
(iii) |
The Board of Directors of the Company accepted the
declination of STEPHENSON. |
| |
|
|
|
(iv) |
During the Company’s two most recent fiscal years ended
September 30, 2013 and 2012 and the subsequent interim periods through the
date of resignation, (a) there were no disagreements with STEPHENSON on
any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure, which disagreements, if not
resolved to the satisfaction of STEPHENSON, would have caused it to make
reference thereto in its reports on the financial statements for such
years and (b) there were no “reportable events” as described in Item
304(a)(1)(v) of Regulation S-K. |
| |
|
|
|
(v) |
On October 27, 2014, the Company provided STEPHENSON with
a copy of this Current Report and has requested that it furnish the
Company with a letter addressing to the United States Securities and
Exchange Commission stating whether it agrees with the above statements. A
copy of such letter is attached as Exhibit 16.1 to this Current Report on
Form 8-K. |
| |
|
|
| (2) |
New Independent Registered Public Accounting
Firm |
| |
|
|
|
On October 27, 2014, the Company, upon the Board of
Directors’ approval, engaged Li and Company, PC (“LICO”) as its new
independent registered public accounting firm to audit and review the
Company’s financial statements effective immediately. During the two most
recent fiscal years ended September 30, 2013 and 2012, and any subsequent
period through the date hereof prior to the engagement of LICO, neither
the Company, nor someone on its behalf, has consulted LICO
regarding: |
| |
|
|
|
(i) |
either: the application of accounting principles to a
specified transaction, either completed or proposed; or the type of audit
opinion that might be rendered on the Company’s financial statements, and
either a written report was provided to the Company or oral advice was
provided that the new independent registered public accounting firm
concluded was an important factor considered by the Company in reaching a
decision as to the accounting, auditing or financial reporting issue;
or |
| |
|
|
|
(ii) |
any matter that was either the subject of a disagreement
as defined in paragraph 304(a)(1)(iv) of Regulation S-K or a reportable
event as described in paragraph 304(a)(1)(v) of Regulation
S-K. |
Section 9. Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
| (a) |
Financial Statements of Businesses Acquired:
None |
| (b) |
Pro-Forma Financial Statements: None |
| (c) |
Exhibits: |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
| |
Medical International Technology,
Inc. |
| |
|
|
| Date: October 30, 2014 |
By: |
/s/
Menassa, Karim |
| |
|
Menassa, Karim, President, CEO, CFO, Interim
Secretary, |
| |
|
Director. |
3
Exhibit 16.1
October 30, 2014
United States Securities and Exchange Commission
100 F
Street, N.E.
Washington DC 20549-7561
| Re: |
Medical International Technology, Inc. |
| |
Commission File Number: 000-31469
|
Commissioners:
We have read Item 4.01 of Form 8-K dated October 29, 2014, of
Medical International Technology, Inc. (the "Company") and are in agreement with
the statements contained therein insofar as they relate to our declination and
our audits of the consolidated balance sheets of Medical International
Technology, Inc. and subsidiaries as of September 30, 2013 and 2012, and the
related consolidated statements of operations, comprehensive loss, stockholders’
deficit, and cash flows for the years then ended.
Very truly yours,
/s/ PS STEPHENSON & CO., P.C.
PS STEPHENSON
& CO., P.C.
Medical International Te... (CE) (USOTC:MDLH)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Medical International Te... (CE) (USOTC:MDLH)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
